NCT06231069

Brief Summary

This study aims to elucidate the effects of 12 weeks of novel multi-nutrient supplementation combined with mixed aerobic/resistance exercise training on skeletal muscle function in young adults. It is hypothesized that multi-nutrient supplementation and mixed aerobic/resistance exercise training (AET/RET) will have interactive effects on muscle fitness.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
11mo left

Started Jan 2030

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2019

Completed
4.6 years until next milestone

First Posted

Study publicly available on registry

January 30, 2024

Completed
6 years until next milestone

Study Start

First participant enrolled

January 20, 2030

Expected
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2030

8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2030

Last Updated

January 30, 2024

Status Verified

January 1, 2024

Enrollment Period

3 months

First QC Date

July 12, 2019

Last Update Submit

January 20, 2024

Conditions

Keywords

Muscle

Outcome Measures

Primary Outcomes (6)

  • Percent change in DXA-obtained muscle mass

    Pre to post change in DXA-obtained muscle mass (%)

    12 weeks

  • Percent change in DXA-obtained fat mass

    Pre to post change in DXA-obtained fat mass (%)

    12 weeks

  • Percent change in DXA-obtained muscle mass to fat mass ratio

    Pre to post change in DXA-obtained muscle mass to fat mass ratio (%)

    12 weeks

  • Percent change in bodyweight

    Pre to post change in bodyweight (%)

    12 weeks

  • Percent change in body mass index

    Pre to post change in body mass index (%)

    12 weeks

  • Percent change in waist to hip ratio

    Pre to post change in waist to hip ratio (%)

    12 weeks

Secondary Outcomes (9)

  • Percent change in slow muscle fiber areas

    12 weeks

  • Percent change in fast muscle fiber areas of quadriceps

    12 weeks

  • Percent change in quadriceps circumference

    12 weeks

  • Percent change in essential amino acid blood levels

    12 weeks

  • Percent change in inflammatory cytokine blood levels (interluekins)

    12 weeks

  • +4 more secondary outcomes

Study Arms (2)

Multi-nutrient supplementation during training

EXPERIMENTAL
Dietary Supplement: Multi-nutrient supplementOther: Exercise

Placebo during training

PLACEBO COMPARATOR
Other: Exercise

Interventions

Multi-nutrient supplementDIETARY_SUPPLEMENT

12 weeks of supplement intake of milk proteins, N-3 PUFAs, creatine, and vitamin D at levels previously shown to augment muscle protein synthesis in young individuals.

Multi-nutrient supplementation during training

12 weeks of short-duration mixed endurance and resistance exercise.

Multi-nutrient supplementation during trainingPlacebo during training

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • non-smoking
  • non-diabetic
  • apparently healthy
  • minimally recreationally active
  • males and females aged 18-30 years

You may not qualify if:

  • pregnancy
  • breast feeding
  • smoking
  • obesity
  • diabetes mellitus
  • cardiovascular disease (recent myocardial infarction (≤ 6 months)
  • hypertension requiring more than 2 medications
  • congestive heart failure requiring more than one medication,
  • renal disease (creatinine \> 130),
  • previous stroke with residual hemiparesis,
  • active musculoskeletal injuries and/or severe osteoarthritis,
  • significant weight loss in the 3-month period prior to the study,
  • vegan diet,
  • dairy protein allergy,
  • muscular dystrophy,
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McMaster University Medical Center

Hamilton, Ontario, L8N 3Z5, Canada

Location

MeSH Terms

Conditions

Sarcopenia

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Mark A Tarnopolsky, MD, PhD

    McMaster University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Following stratification (balanced by age, gender, dietary patterns, and PA levels), randomization into supplement vs. placebo groups will be done by an outside party. Thereafter, GCP (good clinical practice)-certified research coordinators will administer the supplements and collect the baseline/post data in a blinded fashion. These data will be locked and the code for randomization will not be broken until the study is completed. The integrity of the data and the quality of the data analyses will be verified by an outside source. Compliance to GCP will be checked regularly throughout the study period.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: The present study is a randomized, double-blind, placebo-controlled 12-week mixed training and supplementation study (placebo vs. active supplement), with data collection occurring at several different time-points (pre, mid, and post) in young males and females (18-30 years of age).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 12, 2019

First Posted

January 30, 2024

Study Start (Estimated)

January 20, 2030

Primary Completion (Estimated)

April 20, 2030

Study Completion (Estimated)

December 15, 2030

Last Updated

January 30, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations